Elabscience · Newsroom
Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Elabscience®, a global biotechnology company dedicated to advancing life science research, has announced a major upgrade to its antibody product portfolio with the adoption of recombinant rabbit monoclonal antibody technology.November 27, 2025